Authorized generics: A prescription for Hatch-Waxman reform

被引：0

作者：

Chen, Thomas ^{[1
]}

机构：

[1] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA

来源：

关键词：

D O I：

暂无

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

页码：459 / 513

页数：55

共 50 条

[1] Authorized generics: To switch rather than fight - Do the compromises of Hatch-Waxman need a further look?
Peskoe, MP
[J]. GENETIC ENGINEERING NEWS, 2005, 25 (13): : 9 - 10
[2] Beyond Hatch-Waxman
Rouhi, AM
[J]. CHEMICAL & ENGINEERING NEWS, 2002, 80 (38) : 53 - +
[3] BEYOND HATCH-WAXMAN
Ghosh, Shubha
[J]. RUTGERS UNIVERSITY LAW REVIEW, 2015, 67 (03): : 779 - 803
[4] Correcting Hatch-Waxman
Fernandes, Michael
[J]. HEALTH AFFAIRS, 2008, 27 (03) : 902 - 903
[5] The biotechnology industry organization's view on Hatch-Waxman reform
Schmickel, D
[J]. FOOD AND DRUG LAW JOURNAL, 1999, 54 (02) : 241 - 242
[6] HATCH-WAXMAN DEVELOPMENTS IN 1988
SAFIR, PO
[J]. FOOD AND DRUG LAW JOURNAL, 1989, 44 (04): : 359 - 367
[7] Hatch-Waxman changes debated
Ken Chahine
[J]. Nature Biotechnology, 2000, 18 : 710 - 711
[8] Hatch-Waxman and the orange book
MacAlpine, Jill
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[9] Hatch-Waxman changes debated
Chahine, K
[J]. NATURE BIOTECHNOLOGY, 2000, 18 (07) : 710 - 711
[10] HATCH-WAXMAN'S RENEGADES
Thomas, John R.
[J]. UNIVERSITY OF ILLINOIS LAW REVIEW, 2023, (03): : 831 - 879